Edwards Lifesciences Corporation (EW) short interest & options flow
NYSEEdwards Lifesciences reported third-quarter results on the evening of November 4, arriving with the analyst community more aligned to the upside than at any prior point in 2026, and options traders having made the sharpest pivot toward calls in over a month. The clearest pre-print signal came from the options market. The put/call ratio dropped to 0.86 on November 3, sitting 2.2…
EW upgraded to Buy with $113 target by Truist Securities; analyst raises price 18.9% from prior $95 call.
- Market cap
- $57.28B
- Next earnings
- 10 Feb 2027
Key data as of 5 Nov 2026
Latest signals on EW
- Analyst
EW upgraded to Buy with $113 target by Truist Securities; analyst raises price 18.9% from prior $95 call.
- Cost to Borrow
EW cost to borrow doubles to 0.48% in one week, up from 0.24% on October 2, as borrowing demand intensifies ahead of October 23 earnings.
2 Cost to Borrow updates in 30 days
EW news and analysis
RSSNo long-form analysis yet for EW. Pulse alerts and the live data picture are available on ORTEX.
Open EW on ORTEX →Want the live picture for EW?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for EW — free to start on ORTEX.
Sign up for free →Open EW on ORTEX